KRAS and cancer: To bettercharacterize KRAS-targeting compounds for drug discoveryefforts in this space, we developed both biochemical and cell-basedassays to assess target engagement by small molecules, and functionalassays to assess the effect of KRAS degraders on endogenous proteinlevels in relevant cancer cell models.